일본의 면역조직화학 시장 보고서 : 제품, 용도, 최종사용자, 지역별(2025-2033년)

Japan immunohistochemistry market size reached USD 177.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 321.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.1% during 2025-2033. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.

Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.

Japan Immunohistochemistry Market Trends:

The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.

Japan Immunohistochemistry Market Segmentation:

Product Insights:

• Antibodies
• Primary Antibodies
• Secondary Antibodies
• Equipment
• Slide Staining Systems
• Tissue Microarrays
• Tissue Processing Systems
• Slide Scanners
• Others
• Reagents
• Histological Stains
• Blocking sera and Reagents
• Chromogenic Substrates
• Fixation Reagents
• Stabilizers
• Organic Solvents
• Proteolytic Enzymes
• Diluents
• Kits

Application Insights:

• Diagnostics
• Cancer
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Diabetes Mellitus
• Nephrological Diseases
• Drug Testing

End User Insights:

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan immunohistochemistry market?
• What is the breakup of the Japan immunohistochemistry market on the basis of product?
• What is the breakup of the Japan immunohistochemistry market on the basis of application?
• What is the breakup of the Japan immunohistochemistry market on the basis of end user?
• What are the various stages in the value chain of the Japan immunohistochemistry market?
• What are the key driving factors and challenges in the Japan immunohistochemistry?
• What is the structure of the Japan immunohistochemistry market and who are the key players?
• What is the degree of competition in the Japan immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunohistochemistry Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Immunohistochemistry Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Immunohistochemistry Market - Breakup by Product

• 6.1 Antibodies
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Segmentation
    • 6.1.3.1 Primary Antibodies
    • 6.1.3.2 Secondary Antibodies
  • 6.1.4 Market Forecast (2025-2033)
• 6.2 Equipment
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Segmentation
    • 6.2.3.1 Slide Staining Systems
    • 6.2.3.2 Tissue Microarrays
    • 6.2.3.3 Tissue Processing Systems
    • 6.2.3.4 Slide Scanners
    • 6.2.3.5 Others
  • 6.2.4 Market Forecast (2025-2033)
• 6.3 Reagents
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Segmentation
    • 6.3.3.1 Histological Stains
    • 6.3.3.2 Blocking sera and Reagents
    • 6.3.3.3 Chromogenic Substrates
    • 6.3.3.4 Fixation Reagents
    • 6.3.3.5 Stabilizers
    • 6.3.3.6 Organic Solvents
    • 6.3.3.7 Proteolytic Enzymes
    • 6.3.3.8 Diluents
  • 6.3.4 Market Forecast (2025-2033)
• 6.4 Kits
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)

7 Japan Immunohistochemistry Market - Breakup by Application

• 7.1 Diagnostics
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Segmentation
    • 7.1.3.1 Cancer
    • 7.1.3.2 Infectious Diseases
    • 7.1.3.3 Cardiovascular Diseases
    • 7.1.3.4 Autoimmune Diseases
    • 7.1.3.5 Diabetes Mellitus
    • 7.1.3.6 Nephrological Diseases
  • 7.1.4 Market Forecast (2025-2033)
• 7.2 Drug Testing
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Immunohistochemistry Market - Breakup by End User

• 8.1 Hospitals and Diagnostic Laboratories
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Research Institutes
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Others
  • 8.3.1 Historical and Current Market Trends (2019-2024)
  • 8.3.2 Market Forecast (2025-2033)

9 Japan Immunohistochemistry Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Immunohistochemistry Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix